CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-26 | Scherle Peggy Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −1,700 | 33,032 | ||
| 2021-08-25 | Piper Brian Chief Financial Officer | Exercise or conversion | +8,333 | $1.89 | $16K | 8,333 |
| 2021-08-25 | Piper Brian Chief Financial Officer | Sale | −2,100 | $32.44 | $68K | 6,233 |
| 2021-08-25 | Piper Brian Chief Financial Officer | Sale | −3,889 | $33.23 | $129K | 2,344 |
| 2021-08-25 | Piper Brian Chief Financial Officer | Sale | −2,344 | $34.33 | $80K | 0 |
| 2021-08-25 | Piper Brian Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −8,333 | 264,329 | ||
| 2021-08-13 | Scherle Peggy Chief Scientific Officer | Exercise or conversion | +558 | $1.89 | $1K | 173,478 |
| 2021-08-13 | Scherle Peggy Chief Scientific Officer | Exercise or conversion | +1,728 | $1.43 | $2K | 175,206 |
| 2021-08-13 | Scherle Peggy Chief Scientific Officer | Sale | −2,286 | $35.07 | $80K | 172,920 |
| 2021-08-13 | Scherle Peggy Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −558 | 42,672 | ||
| 2021-08-13 | Scherle Peggy Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −1,728 | 34,732 | ||
| 2021-08-05 | Mauro David J Chief Medical Officer | Exercise or conversion | +15,000 | $1.89 | $28K | 15,000 |
| 2021-08-05 | Mauro David J Chief Medical Officer | Sale | −6,116 | $29.93 | $183K | 8,884 |
| 2021-08-05 | Mauro David J Chief Medical Officer | Sale | −2,063 | $31.03 | $64K | 6,821 |
| 2021-08-05 | Mauro David J Chief Medical Officer | Sale | −6,721 | $32.15 | $216K | 100 |
| 2021-08-05 | Mauro David J Chief Medical Officer | Sale | −100 | $32.63 | $3K | 0 |
| 2021-08-05 | Mauro David J Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −15,000 | 167,610 | ||
| 2021-07-27 | Scherle Peggy Chief Scientific Officer | Exercise or conversion | +20,000 | $1.43 | $29K | 192,920 |
| 2021-07-27 | Scherle Peggy Chief Scientific Officer | Sale | −19,320 | $35.45 | $685K | 173,600 |
| 2021-07-27 | Scherle Peggy Chief Scientific Officer | Sale | −680 | $36.09 | $25K | 172,920 |
Page 10 of 19 · 369 trades